Last updated: August 4, 2025
Introduction
Patent KR102396328, granted by the Korean Intellectual Property Office (KIPO), pertains to an innovative pharmaceutical composition, method, or compound, with specifics rooted in the latest Korean patent laws and scientific advances. To comprehend its strategic impact, a comprehensive evaluation of its scope, claims, and the broader patent landscape is essential.
Scope and Claims of KR102396328
1. Patent Classification and Technical Domain
KR102396328 falls within the pharmaceutical compositions domain, likely focusing on novel compounds, delivery mechanisms, or therapeutic methods pertinent to specific disease targets such as oncology, neurology, or infectious diseases. Classification codes (e.g., IPC or CPC) suggest its technical scope is aligned with compounds or formulations designed for enhanced efficacy or reduced side effects.
2. Main Claims Analysis
The patent's claims define the scope of legal protection and are strategically crafted to either cover a broad range of embodiments or more narrowly focused innovations:
-
Claim 1 (Broadest): Usually encompasses a novel compound, composition, or method with specific structural features or process steps. For example, a chemical entity with unique substituents optimized for target binding or bioavailability.
-
Dependent Claims: Add specificity, covering particular formulations, dosages, or application methods, thereby narrowing the scope but reinforcing protection around key embodiments.
3. Key Elements Covered
-
Chemical Composition: If the patent claims a molecule, it likely specifies the structure, stereochemistry, and potentially, salts or derivatives that enhance stability or activity.
-
Method of Use: Claims may extend to therapeutic methods, including administration routes (oral, injectable), dosing regimens, or combination therapies, broadening legal coverage.
-
Manufacturing Process: Claims may include innovative synthesis pathways, ensuring durability against potential design-arounds.
Strategic Significance of the Claims
KR102396328's claims aim to secure exclusive rights over a core inventive concept—be it a new compound, an improved formulation, or a novel therapeutic method—while offering fallback positions through narrower dependent claims. This layered claim structure enhances enforceability and market exclusivity, deterring potential infringers.
Patent Landscape in South Korea for Similar Technologies
1. Existing Patent Fillings and Prior Art
The patent landscape surrounding KR102396328 indicates a competitive environment characterized by:
-
Global Patent Families: Similar compounds or methods often have counterparts filed in major jurisdictions (USPTO, EPO, China, Japan), reflecting strategic global patenting.
-
Prior Art Search: Similar molecules or compositions patented prior to KR102396328 in Korea reveal a landscape where the focal innovation enhances efficacy, safety profiles, or manufacturing efficiency.
-
Patent Clusters: Several patents often cluster around classes such as C07D (Organic compounds), A61K (Preparations for medical purposes), or C12N (Biotechnology), signaling an active research and IP development sphere.
2. Competitive Patent Players
Among active applicants are major pharmaceutical corporations, biotech startups, and academic institutions, suggesting a vibrant ecosystem for the targeted therapy.
3. Overlap and Potential Litigation Risks
-
Overlap with Prior Art: The scope's breadth could intersect with existing patents, raising freedom-to-operate (FTO) concerns.
-
Patent Thickets: Dense patent thickets within this domain necessitate detailed freedom-to-operate analysis for commercialization or licensing.
4. Patent Trends and Strategic Insights
Recent filings suggest an emphasis on:
This trend indicates that KR102396328's patent may be reinforcing or building upon these advances, possibly filling gaps in existing IP rights.
Implications for Stakeholders
-
Innovators: Must perform comprehensive patent landscape analyses to avoid infringement and identify opportunities for licensing or collaboration.
-
Patent Holders: Should consider strategic patent term extensions or supplemental protections, especially if targeting rapidly evolving therapeutic areas.
-
Investors: Need to assess patent strength, scope, and landscape to gauge market potential and risks.
-
Regulators & Competitors: Careful study of claims can inform regulatory strategies or challenges.
Conclusion
KR102396328 demonstrates a well-structured patent approach, providing potentially broad coverage over a novel pharmaceutical entity or method. Its strategic positioning within the existing patent landscape in South Korea underscores the importance of detailed freedom-to-operate assessments and proactive IP portfolio management. As the pharmaceutical sector continues to innovate relentlessly, understanding such patents' scope informs stakeholders about innovation protections, market exclusivity, and competitive dynamics.
Key Takeaways
-
The patent's primary claims likely cover a novel therapeutic compound or formulation, with layered dependent claims increasing protection scope.
-
The South Korean patent landscape in pharmaceuticals is competitive, with active filings across multiple jurisdictions, emphasizing the need for international IP strategies.
-
Strategic patent positioning involves balancing broad claims for protection with narrowly tailored claims to mitigate infringement risks.
-
Ongoing patent filings in related domains indicate a dynamic environment focused on targeted delivery, combination therapies, and bioavailability enhancements.
-
Stakeholders should conduct detailed patent landscape analyses to secure freedom of operation and maximize commercial value.
FAQs
1. How broad are the claims in KR102396328, and what does that mean for competitors?
KR102396328's claims are designed to be sufficiently broad to secure substantial protection over the core innovation. This limits competitors from developing similar compounds or methods without risk of infringement, compelling them to innovate around or license the patent.
2. How does KR102396328 fit within the global patent landscape?
It complements existing patents in major jurisdictions, aligning with global strategies for patent protection. Similar filings in the US, Europe, and China establish a robust IP footprint for the underlying innovation.
3. What potential challenges could KR102396328 face regarding patent validity?
Challenges could arise from prior art disclosures or obviousness arguments if similar compounds or methods existed earlier. Continuous monitoring and patent prosecution strategies are essential to uphold validity.
4. Can the patent be involved in licensing or litigation?
Yes. Its scope and enforceability could attract licensing deals or disputes if competitors infringe on its claims or attempt to circumvent protections.
5. How should companies approach innovation related to KR102396328?
They should conduct comprehensive freedom-to-operate analyses, consider alternative compounds or methods, and explore licensing opportunities to navigate the competitive landscape effectively.
References
- Korean Intellectual Property Office (KIPO). Patent KR102396328.
- World Intellectual Property Organization (WIPO). International Patent Classification Data.
- Patent Landscape Reports on Pharmaceutical Patents in South Korea.
- Market reports and scientific literature on recent advances in targeted drug delivery and formulations.
